Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $378M (100.0% shares, 0.0% debt)

Holdings (25)

ASND ASCENDIS PHARMA A/S 10.0%
Value $37.74M Shares 321,621 Est. Cost $129.01 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 8.9%
Value $33.49M Shares 966,827 Est. Cost $30.31 Unrealized
ARVN ARVINAS INC 8.7%
Value $33.07M Shares 491,333 Est. Cost $75.38 Unrealized -9.6%
LEGN LEGEND BIOTECH CORP 8.0%
Value $30.23M Shares 831,728 Est. Cost $41.11 Unrealized
SIERRA ONCOLOGY INC 6.5%
Value $24.72M Shares 771,314 Est. Cost $25.70 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 6.1%
Value $23.22M Shares 1,256,051 Est. Cost $18.65 Unrealized +3.0%
INCY INCYTE CORP 4.9%
Value $18.62M Shares 234,419 Est. Cost $72.74 Unrealized 0.0%
IVERIC BIO INC 4.1%
Value $15.32M Shares 910,416 Est. Cost $16.73 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 4.0%
Value $15.11M Shares 907,428 Est. Cost $21.56 Unrealized -28.3%
IMCR IMMUNOCORE HLDGS PLC 3.9%
Value $14.93M Shares 499,190 Est. Cost $31.07 Unrealized
HORIZON THERAPEUTICS PUB L 3.8%
Value $14.33M Shares 136,243 Est. Cost $105.21 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 3.6%
Value $13.57M Shares 75,635 Est. Cost $190.51 Unrealized 0.0%
ZNTL ZENTALIS PHARMACEUTICALS INC 3.5%
Value $13.27M Shares 287,577 Est. Cost $77.38 Unrealized -30.3%
SNDX SYNDAX PHARMACEUTICALS INC 3.2%
Value $12.19M Shares 701,356 Est. Cost $17.90 Unrealized -5.9%
CCCC C4 THERAPEUTICS INC 3.2%
Value $12.12M Shares 499,496 Est. Cost $32.19 Unrealized -24.6%
OYSTER PT PHARMA INC 3.0%
Value $11.5M Shares 987,698 Est. Cost $13.68 Unrealized
PRTA PROTHENA CORP PLC 2.6%
Value $9.799M Shares 267,946 Est. Cost $36.05 Unrealized 0.0%
KYMR KYMERA THERAPEUTICS INC 2.5%
Value $9.608M Shares 227,034 Est. Cost $51.11 Unrealized -17.4%
MIRATI THERAPEUTICS INC 2.1%
Value $8.089M Shares 98,383 Est. Cost $146.69 Unrealized
MERUS N V 1.7%
Value $6.603M Shares 249,738 Est. Cost $26.44 Unrealized
VOR BIOPHARMA INC 1.4%
Value $5.402M Shares 894,404 Est. Cost $9.97 Unrealized
ESPR ESPERION THERAPEUTICS INC NE 1.4%
Value $5.37M Shares 1,157,246 Est. Cost $6.99 Unrealized -38.6%
FULC FULCRUM THERAPEUTICS INC 1.3%
Value $5.037M Shares 212,961 Est. Cost $14.15 Unrealized 0.0%
ALPINE IMMUNE SCIENCES INC 0.8%
Value $3.016M Shares 336,229 Est. Cost $8.97 Unrealized
GRACELL BIOTECHNOLOGIES INC 0.5%
Value $1.825M Shares 783,445 Est. Cost $4.91 Unrealized